Literature DB >> 3125849

Isolation of type 5 capsular polysaccharide from Staphylococcus aureus.

J M Fournier1, K Hannon, M Moreau, W W Karakawa, W F Vann.   

Abstract

Clinical surveys have indicated the predominance of type 5 and type 8 capsular polysaccharides among clinical isolates of Staphylococcus aureus. The type 5 capsular polysaccharide was extracted from three clinical isolates of S. aureus grown on solid media, and purified by ion exchange chromatography and gel filtration. Chemical analysis showed that the type 5 capsular polysaccharide is composed of N-acetylfucosamine and N-acetylhexosaminuronic acid. Immunodiffusion and 13C nuclear magnetic resonance experiments showed that the type 5 capsular polysaccharide is both immunologically and chemically distinct from the type 8 capsular polysaccharide and the teichoic acid of S. aureus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3125849     DOI: 10.1016/0769-2609(87)90041-x

Source DB:  PubMed          Journal:  Ann Inst Pasteur Microbiol        ISSN: 0769-2609


  19 in total

1.  Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains.

Authors:  B Poutrel; F B Gilbert; M Lebrun
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

2.  Epidemiological markers for epidemic strain and carrier isolates in an outbreak of nosocomial oxacillin-resistant Staphylococcus aureus.

Authors:  A Bouvet; J M Fournier; A Audurier; C Branger; A Orsoni; C Girard
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Reactivity of coagulase-negative staphylococci isolated from cow and goat milk with monoclonal antibodies to Staphylococcus aureus capsular polysaccharide types 5 and 8.

Authors:  B Poutrel; C Mendolia; L Sutra; J M Fournier
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

4.  Phagocytosis of mastitis isolates of Staphylococcus aureus and expression of type 5 capsular polysaccharide are influenced by growth in the presence of milk.

Authors:  L Sutra; P Rainard; B Poutrel
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

5.  Virulence of Staphylococcus aureus mutants altered in type 5 capsule production.

Authors:  A Albus; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

6.  Phase variation of slime production in Staphylococcus aureus: implications in colonization and virulence.

Authors:  R Baselga; I Albizu; M De La Cruz; E Del Cacho; M Barberan; B Amorena
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

7.  Campylobacter jejuni cocultured with epithelial cells reduces surface capsular polysaccharide expression.

Authors:  N Corcionivoschi; M Clyne; A Lyons; A Elmi; O Gundogdu; B W Wren; N Dorrell; A V Karlyshev; B Bourke
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

Review 8.  Staphylococcus aureus capsular polysaccharides.

Authors:  Katherine O'Riordan; Jean C Lee
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Type 5 and 8 capsular polysaccharides are expressed by Staphylococcus aureus isolates from rabbits, poultry, pigs, and horses.

Authors:  B Poutrel; L Sutra
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

10.  Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships.

Authors:  C Schlichting; C Branger; J M Fournier; W Witte; A Boutonnier; C Wolz; P Goullet; G Döring
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.